首页> 外文OA文献 >Elevation of serum interleukins 8, 4 and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma

【2h】

Elevation of serum interleukins 8, 4 and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma

机译：胃肠道低级B细胞淋巴瘤患者血清白细胞介素8,4和1β水平的升高

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tomoko Miyata-Takata; Katsuyoshi Takata; Tomohiro Toji; Naoe Goto; Senji Kasahara; Takeshi Takahashi; Akira Tari; Mai Noujima-Harada; Takafumi Miyata; Yasuharu Sato; Tadashi Yoshino;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma [J] . Tomoko Miyata-Takata, Katsuyoshi Takata, Tomohiro Toji, Scientific reports. . 2015,第期

机译：胃肠道低级B细胞淋巴瘤患者血清白细胞介素8,4和1β水平的升高
2. Concurrent Elevations of VEGF, Osteopontin and MCP-1 Serum Levels Are Independent Predictors of Survival in Patients with Diffuse Large B-Cell Lymphoma [J] . Duletic-Nacinovic Antica, Gacic Vedrana, Valkovic Toni, Acta Haematologica . 2016,第1期

机译：弥漫性大B细胞淋巴瘤患者中VEGF，骨桥蛋白和MCP-1血清水平的同时升高是存活率的独立预测因素
3. Effect of rituximab combined with CVAD regimen on serum VEGF and β2-MG levels in patients with primary gastrointestinal B-cell lymphoma [J] . Shi-Tong Zhang, Ai-Min Wang, Zhi-Hui Sun, 海南医科大学学报（英文版） . 2019,第012期

机译：利妥昔单抗联合CVAD方案对原发性胃肠道B细胞淋巴瘤患者血清VEGF和β2-MG水平的影响
4. Clinical significance and expression of microRNA-21 in diffuse large B-cell lymphoma cell lines and serum of patients [C] . CHEN Wei-qun, LU Honf-da, KONG De-yong, 2011 Asia-Pacific Conference of tumor biology and medicine . 2011

机译：患者弥漫性大B细胞淋巴瘤细胞株和血清中microRNA-21的表达及临床意义
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Elevation of serum interleukins 8 4 and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma [O] . Tomoko Miyata-Takata, Katsuyoshi Takata, Tomohiro Toji, -1

机译：胃肠道低度B细胞淋巴瘤患者血清白细胞介素8、4和1β水平升高
7. Monocytoid B-Cell Lymphoma(MBCL). Report of 47 Japanese Patients and Review of the Literature with Regard to the Relation between MBCL and Low-Grade B-Cell Lymphoma Arising from the Mucosa-Associated Lymphoid Tissue(MALT Lymphoma). [O] . Hirokazu Nakamine, Toru Takenaka, Eisei Nishino, 1993

机译：单粒细胞致B细胞淋巴瘤（MBCL）。 47例日本患者的报告及对粘液相关淋巴组织（麦芽淋巴瘤）产生的MBCL和低级B细胞淋巴瘤的关系。

Elevation of serum interleukins 8, 4 and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅